Edit
Foamix Pharmaceuticals
http://www.foamix.com/?portfolioCats=34,23,29,35,22,24,30,25,28,31#new_tabFoamix Pharmaceuticals Ltd. (NASDAQ: FOMX), a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary topical foams to address unmet needs in dermatology.
Our clinical stage product candidates include FMX101, our novel minocycline foam for the treatment of moderate-to-severe acne, FMX103 for the treatment of moderate-to-severe rosacea.
Location: Israel, Center District, Rehovot
Member count: 51-200
Total raised: $64M
Founded date: 2003
Investors 1
| Date | Name | Website |
| - | Vivo Capit... | vivocapita... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 30.07.2019 | - | $64M | OrbiMed | - |
Mentions in press and media 2
| Date | Title | Description | Category | Author | Source |
| 21.10.2019 | FDA appro... | Months ago, Foamix leaned on i... | - | Natalie Gr... | endpts.com... |
| 30.07.2019 | Approval ... | In anticipation of a long-... | Financing | Amber Tong | endpts.com... |